Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection

Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection
Cadence Pharmaceuticals, Inc. today announced the launch of OFIRMEV⢠injection, the first and only intravenous formulation of acetaminophen to be approved in the United States.  The U.S.
Read more on PR Newswire via Yahoo! Finance

Study suggests genes influence who we befriend
What draws us to our friends? A new study suggests it goes far beyond shared interests and personality — it’s similarities and differences in our genetic makeup.
Read more on CTV.ca